Virpax Pharmaceuticals Inc (NASDAQ: VRPX) flaunted slowness of -4.42% at $0.59, before settling in for the price of $0.62 at the close. Taking a more long-term approach, VRPX posted a 52-week range of $0.36-$7.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -20.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 74.56%. This publicly-traded company’s shares outstanding now amounts to $8.09 million, simultaneously with a float of $7.59 million. The organization now has a market capitalization sitting at $4.77 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6544, while the 200-day Moving Average is $1.7091.
Virpax Pharmaceuticals Inc (VRPX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Virpax Pharmaceuticals Inc industry. Virpax Pharmaceuticals Inc’s current insider ownership accounts for 6.16%, in contrast to 1.90% institutional ownership.
Virpax Pharmaceuticals Inc (VRPX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Virpax Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 74.56% and is forecasted to reach -0.90 in the upcoming year.
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) Trading Performance Indicators
Let’s observe the current performance indicators for Virpax Pharmaceuticals Inc (VRPX). It’s Quick Ratio in the last reported quarter now stands at 0.08. The Stock has managed to achieve an average true range (ATR) of 0.09.
In the same vein, VRPX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -8.82, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -0.90 at the market close of one year from today.
Technical Analysis of Virpax Pharmaceuticals Inc (VRPX)
Now, what If we examine the latest scores posted by [Virpax Pharmaceuticals Inc, VRPX]. During the last 5-days, its volume was better the volume of 1.83 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 31.54% While, its Average True Range was 0.0885.
Raw Stochastic average of Virpax Pharmaceuticals Inc (VRPX) in the period of the previous 100 days is set at 7.50%, which indicates a major fall in contrast to 16.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 100.17% that was lower than 196.42% volatility it exhibited in the past 100-days period.
